A phase 1b/2a trial evaluated once- and bi-weekly GZR18, a novel GLP-1 analog, in Chinese subjects with obesity/overweight
Pre-clinical studies evaluated the molecular and pharmacological properties of GZR4, an investigational once-weekly insulin analog
Pre-clinical studies evaluated and characterized an ultra-long-acting basal insulin, GZR33, and its premixed formulation GZR101
Os Editores-Chefes do labnews.ai são Marita Vollborn e Vlad Georgescu. Eles são autores best-sellers, escritores de ciência e jornalistas científicos desde 1994.Mais detalhes sobre sua escrita no X-Press Journalistenbüro (https://xpress-journalisten.com).Mais informações na Wikipedia:Sobre Marita: https://de.wikipedia.org/wiki/Marita_Vollborn
Sobre Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu